Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate

Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate is a complex organic compound with the molecular formula C17H19F3N6O6S and CAS number 126535-15-7. This triazine derivative has a molecular weight of 492.4 g/mol and contains multiple functional groups including dimethylamino, trifluoroethoxy, carbamoylsulfamoyl, and methylbenzoate moieties. The compound is classified as a category 2 carcinogen and presents aquatic toxicity concerns.

Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate is an organic solid compound with a molecular weight of 492.4 g/mol. The presence of multiple polar functional groups and the trifluoroethoxy moiety suggests moderate polarity with potential solubility in organic solvents. The compound's complex structure with aromatic rings, triazine core, and multiple heteroatoms influences its physical properties including melting point, solubility profile, and stability characteristics.

Methyl 2-[[4-(dimethylamino)-6-(2,2,2-trifluoroethoxy)-1,3,5-triazin-2-yl]carbamoylsulfamoyl]-3-methylbenzoate is typically used in specialized chemical applications and research. The triazine backbone and complex functional groups suggest potential applications in pharmaceutical intermediates, agrochemical synthesis, or advanced material development. Due to its carcinogenic classification, its use is restricted to professional and industrial applications with appropriate safety controls and regulatory compliance.

Safe handling of this compound requires strict safety measures due to its carcinogenic properties (Carc. 2). Essential protective equipment includes nitrile gloves, safety goggles, and respiratory protection to prevent inhalation. Work should be conducted in well-ventilated areas or under fume hoods. Avoid skin contact, ingestion, and inhalation. Implement proper hygiene measures including thorough handwashing after handling. Follow GHS08 health hazard warnings and establish appropriate workplace exposure controls.

Proper storage requires a cool, dry, well-ventilated area away from direct sunlight and heat sources. The compound should be kept in tightly sealed original containers with appropriate labeling including GHS08 and GHS09 pictograms. Due to its carcinogenic classification, implement controlled access storage with proper inventory tracking. Avoid storage near incompatible materials such as strong oxidizers, acids, or bases. Maintain storage temperature below 25°C and ensure containers are chemically resistant.

Immediate first aid measures are critical due to the carcinogenic nature of this compound. For skin contact, immediately remove contaminated clothing and wash affected area with plenty of soap and water for at least 15 minutes. In case of eye contact, flush immediately with water for 15 minutes. If inhaled, move person to fresh air immediately. For ingestion, do not induce vomiting and seek immediate medical attention. Always inform medical personnel about the substance's carcinogenic properties.

Disposal must comply with local and European waste regulations due to the compound's carcinogenic and aquatic toxicity properties. The substance requires classification as hazardous waste and must be disposed of through licensed hazardous waste contractors. Incineration at high temperatures in approved facilities is typically recommended. Never dispose of in regular waste, sewers, or water systems due to Aquatic Acute 1 and Chronic 1 classifications. Maintain disposal documentation for regulatory compliance.

Transportation follows ADR Class 9 (Miscellaneous dangerous substances) regulations with Packing Group III classification. Packages must display appropriate UN identification numbers and hazard labels including GHS08 and GHS09 pictograms. Use approved packaging materials and ensure proper documentation including transport documents and emergency response information. Vehicles must carry appropriate placards and emergency equipment. Drivers require ADR training certification for Class 9 materials. Avoid transport during extreme temperatures.

Yes, this compound is subject to comprehensive European chemical regulations. Under CLP Regulation, it requires classification as Carcinogenic Category 2 and Aquatic toxicity Categories 1. REACH registration requirements apply for commercial use above tonnage thresholds. Workplace exposure limits and occupational health monitoring may be mandatory. The substance is not currently listed as SVHC but faces potential regulatory scrutiny due to its hazard profile. Users must comply with national implementation of EU chemical safety legislation.

OYSI serves as a specialized European distributor for this compound, providing reliable supply to qualified industrial and research customers. As a professional chemical distributor, OYSI ensures full regulatory compliance, proper documentation, and safe packaging for transportation. Due to the substance's carcinogenic classification, purchases require verification of legitimate use, appropriate safety infrastructure, and regulatory compliance. Contact OYSI directly for availability, technical specifications, safety data sheets, and regulatory support for your specific application requirements.